Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Not applicableStudy completedNCT00100581
What this trial is testing

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 2
Testing effectiveness (Phase 2)Study completedNCT00991289
What this trial is testing

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Who this might be right for
HIV InfectionHepatitis C Infection
National Institute of Allergy and Infectious Diseases (NIAID) 68
Large-scale testing (Phase 3)Study completedNCT02032888
What this trial is testing

Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 238
Not applicableStudy completedNCT02597790
What this trial is testing

A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects

Who this might be right for
HIVHepatitis C
University of California, Los Angeles 87
Not applicableStudy completedNCT02196064
What this trial is testing

Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."

Who this might be right for
Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects
Fundación Pública Andaluza Progreso y Salud 519
Testing effectiveness (Phase 2)Study completedNCT01878799
What this trial is testing

Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV

Who this might be right for
Hepatitis CHIV
National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)Study completedNCT01482767
What this trial is testing

Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 262
Post-approval studies (Phase 4)Study completedNCT01222611
What this trial is testing

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Who this might be right for
Chronic HIV InfectionHCV Coinfection
Fundacion SEIMC-GESIDA 42
Not applicableStudy completedNCT00006643
What this trial is testing

Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 44
Post-approval studies (Phase 4)Study completedNCT02533934
What this trial is testing

Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant

Who this might be right for
HIVHepatitis CCirrhosis
University of California, San Francisco 68
Large-scale testing (Phase 3)Study completedNCT01500616
What this trial is testing

Telaprevir Open-Label Study in Co-Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen-Cilag International NV 122
Post-approval studies (Phase 4)Ended earlyNCT00194857
What this trial is testing

Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin

Who this might be right for
AnemiaNeutropeniaHepatitis C Virus+1 more
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)WithdrawnNCT02556086
What this trial is testing

A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Large-scale testing (Phase 3)Ended earlyNCT01467479
What this trial is testing

Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 185
Testing effectiveness (Phase 2)Study completedNCT00078403
What this trial is testing

Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)

Who this might be right for
HIV InfectionsHepatitis CLiver Disease
National Institute of Allergy and Infectious Diseases (NIAID) 333
Testing effectiveness (Phase 2)Study completedNCT00665353
What this trial is testing

Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance

Who this might be right for
HIV-1 and Hepatitis C Co-Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 19